Involuntary movements – Related resources
22.09.2014 • Sonuncu dəyişiklik 17.01.2008
This article is created and updated by the EBMG Editorial Team
Cochrane reviews
- GABA agonists (baclofen, progabide, sodium valproate, tetrahydroisoxazolopyridine) may cause several adverse effects, and their effectiveness in people with antipsychotic-induced tardive dyskinesia is inconclusive and unconvincing .
- Benzodiazepines may have some effect in neuroleptic induced tardive dyskinesia but the evidence is inconclusive .
- Neuroleptic reduction or specific neuroleptic drugs as treatments for tardive dyskinesia are probably not effective .
- According to single studies, either ceruletide, gamma-linolenic acid, oestrogen, lithium, phenylalanine, or insulin may not be effective for reduction of neuroleptic induced tardive dyskinesia .
Beta-blocking drugs are probably not effective for akathisia .
- There is no evidence that vitamin E improves symptoms of neuroleptic-induced tardive dyskinesia .
Literature
-
Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry 2004 Jul;75(7):951-7.
Trost M. Dystonia update. Curr Opin Neurol 2003 Aug;16(4):495-500.
Rodnitzky RL. Drug-induced movement disorders. Clin Neuropharmacol 2002 May-Jun;25(3):142-52.
- Correll CU, Schenk EM. Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry 2008 Mar;21(2):151-6
- Encarnacion EV, Hauser RA. Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments. Eur Neurol 2008;60(2):57-66
- Quartarone A, Rizzo V, Morgante F. Clinical features of dystonia: a pathophysiological revisitation. Curr Opin Neurol 2008 Aug;21(4):484-90
- Walker FO. Huntington's disease. Lancet 2007 Jan 20;369(9557):218-28
- Wild EJ, Tabrizi SJ. The differential diagnosis of chorea. Pract Neurol 2007 Nov;7(6):360-73